1. Home
  2. Clinical Topics
  3. Should codeine be phased out?
Clinical TopicsPain ManagementPatient SafetyPediatricsWeb ExclusivesWorkplace Management

Should codeine be phased out?

Share

An editorial in CMAJ, the journal of the Canadian Medical Association, raises concerns about a genetic variation and adverse effects from codeine and suggests it may be time to phase it out, especially for infants and children, who are at the highest risk, in favor of morphine, codeine’s active metabolite. Toronto’s Hospital for Sick Children has already removed codeine from its formulary. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts